| Bevacizumab plus radiotherapy–temozolomide for newly diagnosed glioblastoma OL Chinot, W Wick, W Mason, R Henriksson, F Saran, R Nishikawa, ... New England Journal of Medicine 370 (8), 709-722, 2014 | 2634 | 2014 |
| EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood M Weller, M van den Bent, M Preusser, E Le Rhun, JC Tonn, G Minniti, ... Nature reviews Clinical oncology 18 (3), 170-186, 2021 | 1081 | 2021 |
| Short-course radiation plus temozolomide in elderly patients with glioblastoma JR Perry, N Laperriere, CJ O’Callaghan, AA Brandes, J Menten, C Phillips, ... New England Journal of Medicine 376 (11), 1027-1037, 2017 | 999 | 2017 |
| European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas M Weller, M Van Den Bent, JC Tonn, R Stupp, M Preusser, ... The lancet oncology 18 (6), e315-e329, 2017 | 982 | 2017 |
| Radiotherapy for glioblastoma in the elderly F Keime-Guibert, O Chinot, L Taillandier, S Cartalat-Carel, M Frenay, ... New england journal of medicine 356 (15), 1527-1535, 2007 | 934 | 2007 |
| EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma M Weller, M Van Den Bent, K Hopkins, JC Tonn, R Stupp, A Falini, ... The lancet oncology 15 (9), e395-e403, 2014 | 795 | 2014 |
| Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook J Garcia, HI Hurwitz, AB Sandler, D Miles, RL Coleman, R Deurloo, ... Cancer treatment reviews 86, 102017, 2020 | 724 | 2020 |
| Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study BG Baumert, ME Hegi, MJ van den Bent, A von Deimling, T Gorlia, ... The Lancet Oncology 17 (11), 1521-1532, 2016 | 486 | 2016 |
| Recent trends in epidemiology of brain metastases: an overview E Tabouret, O Chinot, P Metellus, A Tallet, P Viens, A Goncalves Anticancer research 32 (11), 4655-4662, 2012 | 409 | 2012 |
| Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3 … MJ van den Bent, B Baumert, SC Erridge, MA Vogelbaum, AK Nowak, ... The Lancet 390 (10103), 1645-1653, 2017 | 364 | 2017 |
| Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis P Metellus, B Coulibaly, C Colin, AM de Paula, A Vasiljevic, D Taieb, ... Acta neuropathologica 120, 719-729, 2010 | 316 | 2010 |
| Patients with proneural glioblastoma may derive overall survival benefit from the addition of bevacizumab to first-line radiotherapy and temozolomide: retrospective analysis of … T Sandmann, R Bourgon, J Garcia, C Li, T Cloughesy, OL Chinot, W Wick, ... Journal of clinical oncology 33 (25), 2735, 2015 | 312 | 2015 |
| Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor … MJ Van den Bent, MJB Taphoorn, AA Brandes, J Menten, R Stupp, ... Journal of clinical oncology 21 (13), 2525-2528, 2003 | 311 | 2003 |
| Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research … K Hoang-Xuan, L Taillandier, O Chinot, P Soubeyran, U Bogdhan, ... Journal of Clinical Oncology 21 (14), 2726-2731, 2003 | 269 | 2003 |
| Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas A Gonzalez-Aguilar, A Idbaih, B Boisselier, N Habbita, M Rossetto, ... Clinical cancer research 18 (19), 5203-5211, 2012 | 260 | 2012 |
| Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide OL Chinot, M Barrie, S Fuentes, N Eudes, S Lancelot, P Metellus, ... Journal of Clinical Oncology 25 (12), 1470-1475, 2007 | 256 | 2007 |
| Comparative assessment of 5 methods (methylation‐specific polymerase chain reaction, methylight, pyrosequencing, methylation‐sensitive high‐resolution melting, and … V Quillien, A Lavenu, L Karayan‐Tapon, C Carpentier, M Labussière, ... Cancer 118 (17), 4201-4211, 2012 | 243 | 2012 |
| AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme OL Chinot, T de La Motte Rouge, N Moore, A Zeaiter, A Das, H Phillips, ... Advances in therapy 28, 334-340, 2011 | 233 | 2011 |
| A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma AA Brandes, AF Carpentier, S Kesari, JM Sepulveda-Sanchez, ... Neuro-oncology 18 (8), 1146-1156, 2016 | 232 | 2016 |
| Radiotherapy or autologous stem-cell transplantation for primary CNS lymphoma in patients 60 years of age and younger: results of the intergroup ANOCEF-GOELAMS randomized phase … C Houillier, L Taillandier, S Dureau, T Lamy, M Laadhari, O Chinot, ... Journal of Clinical Oncology 37 (10), 823-833, 2019 | 216 | 2019 |
